- Home
- GERN vs LPG Comparison
GERN vs LPG Comparison
Compare GERN & LPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- LPG
- Stock Information
- Founded
- GERN 1990
- LPG 2013
- Country
- GERN United States
- LPG United States
- Employees
- GERN N/A
- LPG N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- LPG Marine Transportation
- Sector
- GERN Health Care
- LPG Consumer Discretionary
- Exchange
- GERN Nasdaq
- LPG Nasdaq
- Market Cap
- GERN 974.5M
- LPG 913.3M
- IPO Year
- GERN 1996
- LPG 2014
- Fundamental
- Price
- GERN $1.32
- LPG $29.11
- Analyst Decision
- GERN Buy
- LPG Strong Buy
- Analyst Count
- GERN 8
- LPG 1
- Target Price
- GERN $3.71
- LPG $35.00
- AVG Volume (30 Days)
- GERN 9.4M
- LPG 662.4K
- Earning Date
- GERN 08-07-2025
- LPG 07-31-2025
- Dividend Yield
- GERN N/A
- LPG 11.06%
- EPS Growth
- GERN N/A
- LPG N/A
- EPS
- GERN N/A
- LPG 2.14
- Revenue
- GERN $116,293,000.00
- LPG $349,670,662.00
- Revenue This Year
- GERN $160.12
- LPG $12.19
- Revenue Next Year
- GERN $55.01
- LPG N/A
- P/E Ratio
- GERN N/A
- LPG $13.51
- Revenue Growth
- GERN 22264.04
- LPG N/A
- 52 Week Low
- GERN $1.17
- LPG $16.66
- 52 Week High
- GERN $5.06
- LPG $42.38
- Technical
- Relative Strength Index (RSI)
- GERN 40.66
- LPG 78.21
- Support Level
- GERN $1.36
- LPG $26.09
- Resistance Level
- GERN $1.48
- LPG $26.72
- Average True Range (ATR)
- GERN 0.09
- LPG 0.82
- MACD
- GERN -0.02
- LPG 0.27
- Stochastic Oscillator
- GERN 7.41
- LPG 99.15
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About LPG Dorian LPG Ltd.
Dorian LPG Ltd is an international liquefied petroleum gas shipping company focused on owning and operating gas carriers, or VLGCs. The company currently owns and operates around 22 modern VLGCs, including nineteen new fuel-efficient 84,000 cbm ECO-design VLGCs. Dorian LPG has offices in Connecticut, USA, London, United Kingdom, and Athens, Greece.